The Trump administration’s steep tariffs on Chinese imports are threatening to further destabilize hospitals’ bottom lines by ...

Healthcare leaders might be too confident about their AI readiness, according to new research. It showed that 70% of leaders ...

The Trump administration aims to change the Medicare Drug Price Negotiation Program in a way that would delay when certain ...

Roche said it will expand existing sites and construct new U.S. manufacturing and R&D infrastructure in areas such as gene ...

The future of telehealth is trust, combined with patient education. As the market matures, all parties — providers, ...

In a new report, the Peterson Center on Healthcare made policy recommendations on reimbursement, access and data collection ...

The FDA laid out a three-year roadmap to phase out animal toxicity testing in drug research. In addition to organoids and lab ...

Contraline — a trailblazer in the nascent male contraceptive market — released promising new trial data on Thursday showing that the company’s contraceptive hydrogel has demonstrated safety ...

The U.S. health insurance industry — a $1.29 trillion giant — is under strain. Soaring healthcare costs, policy shake-ups, and long-standing access gaps are squeezing not just insurers, but ...